Monitoring of Intracellular l‐βD‐Arabinofuranosylcytosine 5′‐Triphosphate in 1‐β‐D‐Arabinofuranosylcytosine Therapy at Low and Conventional Doses

1‐β‐D‐Arabinofuranosylcytosine (ara‐C) is used empirically at a low, conventional, or high dose. Ara‐C therapy may be optimal if it is directed by the clinical pharmacokinetics of the intracellular active metabolite of ara‐C, 1‐β‐D‐arabinofuranosylcytosine 5′‐triphosphate (ara‐CTP). However, ara‐CTP...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamauchi, Takahiro, Kawai, Yasukazu, Kishi, Shinji, Goto, Nobuyuki, Urasaki, Yoshimasa, Imamura, Shin, Fukushima, Toshihiro, Yoshida, Akira, Iwasaki, Hiromichi, Tsutani, Hiroshi, Masada, Mikio, Ueda, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2001
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926735/
https://www.ncbi.nlm.nih.gov/pubmed/11376564
http://dx.doi.org/10.1111/j.1349-7006.2001.tb01128.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926735/
https://www.ncbi.nlm.nih.gov/pubmed/11376564
http://dx.doi.org/10.1111/j.1349-7006.2001.tb01128.x

Ejemplares similares